The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ASTERIAS BIOTHERAPEUTICS INC | COM SER A | 04624N107 | 6,449 | 1,641,025 | SH | DFND | 1 | 1,641,025 | 0 | 0 | |
| BIOTIME INC | COM | 09066L105 | 82,811 | 21,864,396 | SH | DFND | 1 | 21,864,396 | 0 | 0 | |
| CYNOSURE INC | CL A | 232577205 | 40,961 | 916,975 | SH | DFND | 1 | 916,975 | 0 | 0 | |
| IMPRIVATA INC | COM | 45323J103 | 7,554 | 668,526 | SH | DFND | 1 | 668,526 | 0 | 0 | |
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 28,155 | 250,000 | SH | DFND | 1 | 250,000 | 0 | 0 | |
| ONCOCYTE CORPORATION | COM | 68235C107 | 6,833 | 1,093,219 | SH | DFND | 1 | 1,093,219 | 0 | 0 | |
| MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 238,207 | 1,599,136 | SH | DFND | 1 | 1,599,136 | 0 | 0 | |
| MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 120,898 | 1,619,968 | SH | DFND | 1 | 1,619,968 | 0 | 0 | |
| STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 61,739 | 8,646,923 | SH | DFND | 1 | 8,646,923 | 0 | 0 | |